Cargando…

Is there any benefit to particles over photon radiotherapy?

Particle, essentially, proton radiotherapy (RT) could provide some benefits over photon RT, especially in reducing the side effects of RT. We performed a systematic review to identify the performed randomised clinical trials (RCTs) and ongoing RCTs comparing particle RT with photon therapy. So far,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goossens, Maria E, Van den Bulcke, Marc, Gevaert, Thierry, Meheus, Lydie, Verellen, Dirk, Cosset, Jean-Marc, Storme, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974365/ https://www.ncbi.nlm.nih.gov/pubmed/32010206 http://dx.doi.org/10.3332/ecancer.2019.982

Ejemplares similares

Breast Conserving Treatment for Breast Cancer: Dosimetric Comparison of Sequential versus Simultaneous Integrated Photon Boost
por: Van Parijs, Hilde, et al.
Publicado: (2014)

Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer
por: Engels, Benedikt, et al.
Publicado: (2012)

Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients
por: Vinh-Hung, Vincent, et al.
Publicado: (2022)

Implementation of HybridArc treatment technique in preoperative radiotherapy of rectal cancer: dose patterns in target lesions and organs at risk as compared to helical Tomotherapy and RapidArc
por: Gevaert, Thierry, et al.
Publicado: (2012)

Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery
por: Van Parijs, Hilde, et al.
Publicado: (2014)

A diagnostic tool for basic daily quality assurance of a tomotherapy Hi•Art machine
por: de Vondel, Iwein Van, et al.
Publicado: (2009)

Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial
por: Van Parijs, Hilde, et al.
Publicado: (2012)

Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer: Post Hoc Utility of a Mean Absolute Dose Deviation Penalty Score
por: Heymann, Steve, et al.
Publicado: (2020)

Feasibility of using the Vero SBRT system for intracranial SRS
por: Burghelea, Manuela, et al.
Publicado: (2014)

In vivo dosimetry for patients with prostate cancer to assess possible impact of bladder and rectum preparation
por: Fiagan, Yawo A.C., et al.
Publicado: (2020)

The Mouse IAPE Endogenous Retrovirus Can Infect Cells through Any of the Five GPI-Anchored EphrinA Proteins
por: Dewannieux, Marie, et al.
Publicado: (2011)

The mouse IAPE endogenous retrovirus can infect cells through any of the five GPI-anchored EphrinA proteins
por: Dewannieux, Marie, et al.
Publicado: (2011)

Comparing treatment uncertainty for ultra- vs. standard-hypofractionated breast radiation therapy based on in-vivo dosimetry
por: Fiagan, Yawo A.C., et al.
Publicado: (2022)

Inconsistencies and questionable reliability of the publication “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF” by Yamamoto et al
por: Ugarte, Ana, et al.
Publicado: (2014)

Are there any benefits of exercise training in cancer cachexia?
por: Argilés, Josep M., et al.
Publicado: (2012)

Assessing the impact of adaptations to the clinical workflow in radiotherapy using transit in vivo dosimetry
por: Bossuyt, Evy, et al.
Publicado: (2023)

Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?
por: Gevaert, Thierry, et al.
Publicado: (2016)

Evaluation of automated pre-treatment and transit in-vivo dosimetry in radiotherapy using empirically determined parameters
por: Bossuyt, Evy, et al.
Publicado: (2020)

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
por: Verbaanderd, Ciska, et al.
Publicado: (2020)

Towards a Pathogenic Escherichia coli Detection Platform Using Multiplex SYBR®Green Real-Time PCR Methods and High Resolution Melting Analysis
por: Kagkli, Dafni-Maria, et al.
Publicado: (2012)

Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
por: Wang, Hui, et al.
Publicado: (2017)

Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis?
por: Fourie, Natasha, et al.
Publicado: (2022)

Development, Testing, and Implementation of the Belgian Patient Reported Experience Measure for Pancreatic Cancer Care (PREPARE) Project: Protocol for a Multi-Method Research Project
por: Moens, Katrien, et al.
Publicado: (2022)

Pooled platelet concentrates provide a small benefit over single-donor platelets for patients with platelet refractoriness of any etiology
por: Chu, Ying-Hsia, et al.
Publicado: (2021)

Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy
por: Chen, Chu-Ying, et al.
Publicado: (2022)

Hand-over of CB Chairmanship Any other business
por: CERN. Geneva. Audiovisual Unit
Publicado: (1995)

From Photon Beam to Accelerated Particle Beam: Antimetastasis Effect of Combining Radiotherapy With Immunotherapy
por: Ma, Liqiu
Publicado: (2022)

CP violation in particle physics and cosmology: is there any connection?
por: Masiero, A, et al.
Publicado: (1982)

Any data, any time, any where
por: Malik, Sudhir
Publicado: (2013)

Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?
por: Mughal, Mohsin S, et al.
Publicado: (2020)

Simulation of between Repeat Variability in Real Time PCR Reactions
por: Lievens, Antoon, et al.
Publicado: (2012)

The power of charm: how to win anyone over in any situation
por: Tracy, Brian, et al.
Publicado: (2006)

Have Smooth-Faced Pluggers Any Advantage over Serrated?
por: Williams, N. W.
Publicado: (1874)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc
por: Burghelea, Manuela, et al.
Publicado: (2016)

SUSY particle production in photon-photon collisions
por: Klasen, M
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_1gdgkktdl52t85olp0rpe9rouv